• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 1514
  • 801
  • 125
  • 101
  • 91
  • 53
  • 52
  • 47
  • 45
  • 22
  • 15
  • 15
  • 15
  • 15
  • 15
  • Tagged with
  • 3019
  • 1280
  • 821
  • 608
  • 532
  • 515
  • 450
  • 397
  • 361
  • 266
  • 234
  • 189
  • 188
  • 187
  • 181
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
341

CISPLATIN RELEASE CHARACTERISTICS FROM AMORPHOUS CALCIUM POLYPHOSPHATE MATRICES FOR THE ADJUNCTIVE TREATMENT OF ORAL SQUAMOUS CELL CARCINOMA

Shaffner, Matthew 07 March 2014 (has links)
Cisplatin is an effective chemotheraputic agent for head and neck squamous cell carcinoma particularly in conjunction with radiation therapy. Unfortunately, its cytotoxic profile and associated systemic side effects limit its clinical efficacy. A localized delivery system was developed for cisplatin by processing calcium polyphosphate (CPP) in a multistep gelling protocol, with the goal of limiting its systemic toxicity and enhancing its overall clinical applicability. In addition, a novel method for processing the material was examined utilizing cold isostatic pressure (CIP) to allow for miniaturization of the system into an implantable device. The integration of cisplatin into the matrix was examined for efficient and dose dependent loading via dissolution of the final product and measurement of platinum concentrations by inductively coupled plasma optical emission spectrometry (ICP-OES). Drug release was measured in vitro by placing the CPP-cisplatin matrix into TRIS buffer solution while measuring the platinum concentration at given intervals from 0.5 hours to 14 days. The cytotoxicity of the cisplatin against L1210 cells was examined using an MTT assay following a 12-hour elution. The material demonstrated a predictable and dose dependent loading of cisplatin, although the release of the drug showed variability exemplified by a more pronounced burst release with aging of the stock CPP glass particulate. The CPP/cisplatin matrix exhibited cytotoxic effects after processing. This work suggests that further evaluation of this material as a matrix for cisplatin delivery should be undertaken in an attempt to normalize release, maximize the concentration within the system and further optimize the bead format in order to improve the potential for clinical usage.
342

Multidisciplinary Management of Small Cell Carcinoma of the Breast: A Case Report

OHAMA, TOSHIHIRO, ODA, KOJI, KAWADA, KENJI, YATABE, YASUSHI, AKAHANE, KAZUHISA, FUJII, MASAHIRO, MURATA, TORU 02 1900 (has links)
No description available.
343

Tumores de la glándula adrenal / A morphological and statistical survey in 10.000 slaughtered cow. Tumors of the adrenal gland

Idiart, Julio Roberto January 1980 (has links)
Se investigan la prevalencia y características generales de los tumores de la glándula adrenal en 10.000 vacas de 5 a 13 años, faenadas en un frigorífico de la Provincia de Buenos Aires. Se describen las características macroscópicas e histopatológicas de 136 lesiones halladas en 124 animales, que incluyen 33 feocromocitomas, 26 adenomas y 18 carcinomas corticales, 22 neurofibromas y un neuroblastoma. Igualmente se consideran las lesiones seudotumorales que incluyen hiperplasia cortical focal, "mielolipoma", focos de tejido hemopoyético y nódulos de células claras. Se analizan los datos obtenidos sobre influencia geográfica y la edad, tipo y estado general de los animales afectados. / The prevalence and general characteristics of adrenal tumors among 10.000 cows from 5 to 13 years old, slaughtered at an establishent in Buenos Aires province, were investigated. Macroscopic and histopathologic charasteristics of 136 lesions found in 124 animals were described; they included 33 pheochromocytomas, 26 adenomas and 18 cortical carcinomas, 22 neurofibromas and 1 neuroblastoma. Tumor-like lesions were also considered; they included focal cortical hyperplasia, "myelolipoma", haemotopoietic foci and clear cell nodule. Collected data on geographic influence, age, breed and carcass condition of the affected animals were evaluated.
344

Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements

Lobo, Nazleen 05 December 2013 (has links)
While extirpative surgery is curative for localized clear cell renal cell carcinoma (ccRCC), many patients develop recurrences or present with metastatic disease. Several aspects of ccRCC biology have been investigated, but these have been done in cell lines, which are known to poorly represent the tumour. Since cell lines are amenable to a wide array of experimental testing, the studies presented here demonstrate a novel method to generate ccRCC cell lines from primary tumours, which increases the rate of primary tumour cell line generation four fold. Additionally, ccRCC cells do not grow in serum-free media, which has been shown to be beneficial in other cancers. Therefore, we interrogated the effect of exogenous growth factors to optimize our serum-free media growth conditions, among which TGFb1 appeared to elicit the largest mitogenic effect. Once optimized, these findings will provide a valuable tool for understanding ccRCC tumour cell biology and identifying therapeutic targets.
345

Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements

Lobo, Nazleen 05 December 2013 (has links)
While extirpative surgery is curative for localized clear cell renal cell carcinoma (ccRCC), many patients develop recurrences or present with metastatic disease. Several aspects of ccRCC biology have been investigated, but these have been done in cell lines, which are known to poorly represent the tumour. Since cell lines are amenable to a wide array of experimental testing, the studies presented here demonstrate a novel method to generate ccRCC cell lines from primary tumours, which increases the rate of primary tumour cell line generation four fold. Additionally, ccRCC cells do not grow in serum-free media, which has been shown to be beneficial in other cancers. Therefore, we interrogated the effect of exogenous growth factors to optimize our serum-free media growth conditions, among which TGFb1 appeared to elicit the largest mitogenic effect. Once optimized, these findings will provide a valuable tool for understanding ccRCC tumour cell biology and identifying therapeutic targets.
346

Analyse qualitätsrelevanter Parameter von Patienten mit einem kolorektalen Karzinom vor und nach Gründung eines Darmzentrums

Jores, Teréz 07 April 2015 (has links) (PDF)
In der vorliegenden Arbeit werden mit den Jahren 2005/2006 und 2007 qualitätsrelevante Parameter von Patienten mit einem kolorektalen Karzinom vor und unmittelbar nach Gründung des Darmzentrums an der Universitätsklinik Leipzig analysiert. Ziel dieser Arbeit war es zu untersuchen, welchen Einfluss die Gründung eines zertifizierten Darmzentrums kurzfristig auf die Behandlungsqualität von Patienten mit einem kolorektalen Karzinom hat. Die durch die Deutsche Krebsgesellschaft festgelegten Struktur- bzw. Ergebnisparameter wurden für die Jahre 2005 und 2006 retrospektiv - ab 2007 kontinuierlich erfasst. Die meisten, aber nicht alle Anforderungen der Deutschen Krebsgesellschaft wurden erreicht, bzw. umgesetzt. So zeigte sich eine bessere Dokumentation der Behandlung, insbesondere in der Pathologie. Ausserdem konnte eine Zunahme der Fallzahlen verzeichnet werden. Die Ergebnisse der Arbeit zeigen, dass durch eine Zertifizierung als Darmzentrum zunächst eine Verbesserung der Dokumentation und Standardisierung der Therapie bewirkt werden kann. Kurzfristig kann in einigen, aber nicht allen Behandlungsparametern, eine Qualitätsverbesserung, insbesondere in der Chirurgie, erreicht werden.
347

Pre-clinical evaluation of P13K and MEK inhibitor combinations in colorectal cancer tumour models

Haagensen, Emma Joanne January 2012 (has links)
No description available.
348

A Cytokine Odyssey: From Interleukin-2 Signaling to Cytokine Therapy for Cancer

Tran, Eric 29 October 2013 (has links)
T cells are a crucial component of the immune system and play an important role in responses to pathogens, tumours, and transplanted tissues. In many human cancers, elevated numbers of tumour-infiltrating CD8+ killer T cells are associated with favourable outcomes, suggesting that enhancing T-cell responses could provide major therapeutic benefit for cancer patients. Thus, identifying factors that can promote protective T-cell responses is of great clinical importance. The cytokine interleukin-2 (IL-2) is a major inducer of T-cell proliferation and differentiation, and is used clinically to treat melanoma and renal cell carcinoma. The first two chapters of this thesis focus on the biochemical mechanisms by which IL-2 induces T-cell proliferation. By using mutant and chimeric cytokine receptors expressed in lymphocyte cell lines, the interplay between Shc and STAT5, two major mitogenic signaling pathways activated by the IL-2 receptor, are investigated, revealing an essential synergy between the two pathways for optimal lymphocyte proliferation. The third chapter of this thesis describes work done to identify cytokines that promote T-cell responses within the ovarian cancer microenvironment. In human diseases such as HIV/AIDS and cancer, high numbers of “polyfunctional” T cells (i.e., T cells capable of multiple effector functions) are associated with favourable outcomes. Using clinical ovarian cancer samples in a novel ex vivo assay, it was found that the ovarian tumour environment inhibits polyfunctional T-cell responses to varying extents among patients. After surveying a large panel of cytokines, the cytokine combination of IL-2, IL-12, and IL-18 was found to overcome the immunosuppressive environment to potently enhance CD8+ T-cell proliferation and polyfunctionality in all patient samples. The polyfunctional profiles induced by these cytokines are associated with protective immunity in various human conditions. Thus, these findings suggest that given the right signals, T cells can become highly polyfunctional effectors in the ovarian cancer microenvironment, which offers promise for the development of effective T-cell based therapies for this clinically challenging disease. / Graduate / 0982
349

The Role of Hedgehog-Gli Pathway Regulators in Skin Development and Tumorigenesis

Li, Zhu Juan 08 August 2013 (has links)
Proper control of Hedgehog (Hh) signaling is critical for hair follicle morphogenesis and ectopic Hh pathway activity is a hallmark of basal cell carcinoma (BCC), the most common type of skin cancer. Mutations in Hh pathway components such as the Hh-binding receptor PATCHED1 (PTCH1) are frequently found in BCC. However, how Hh pathway activation disrupts normal skin homeostasis to promote BCC formation remains poorly understood. Gli2, the major mediator of Hh signaling is essential for hair follicle development and its overexpression in the epidermis induces BCC formation. Despite the importance of Gli2 in the skin, how it is regulated during skin development and tumorigenesis is unclear. Using a genetic approach with loss-of-function mouse mutants and primary keratinocyte cultures, I have uncovered the distinct and overlapping functions of Sufu and Kif7, two evolutionarily conserved regulators of the Hh pathway, during skin development and tumorigenesis. Sufu and Kif7 play opposing roles in Hh signaling through the regulation of Gli2 subcellular distribution, and Kif7 performs distinct Sufu-dependent and –independent functions. In addition, deletion of both Sufu and Kif7 in embryonic skin leads to complete loss of follicular fate and compromised epidermal differentiation. In the adult skin, inactivation of Sufu does not drive BCC formation and requires additional genetic alterations such as the loss of Kif7. Using a Ptc1 mouse model for BCC, I have identified previously unrecognized molecular pathways and cellular events involved in BCC pathogenesis. This includes, aberrant cell cycle progression, loss of cell cycle checkpoint regulation, and suppression of the p53 response. Overall my work provides critical insight into the molecular control of Hh signaling and the downstream events driving BCC formation.
350

The Role of Hedgehog-Gli Pathway Regulators in Skin Development and Tumorigenesis

Li, Zhu Juan 08 August 2013 (has links)
Proper control of Hedgehog (Hh) signaling is critical for hair follicle morphogenesis and ectopic Hh pathway activity is a hallmark of basal cell carcinoma (BCC), the most common type of skin cancer. Mutations in Hh pathway components such as the Hh-binding receptor PATCHED1 (PTCH1) are frequently found in BCC. However, how Hh pathway activation disrupts normal skin homeostasis to promote BCC formation remains poorly understood. Gli2, the major mediator of Hh signaling is essential for hair follicle development and its overexpression in the epidermis induces BCC formation. Despite the importance of Gli2 in the skin, how it is regulated during skin development and tumorigenesis is unclear. Using a genetic approach with loss-of-function mouse mutants and primary keratinocyte cultures, I have uncovered the distinct and overlapping functions of Sufu and Kif7, two evolutionarily conserved regulators of the Hh pathway, during skin development and tumorigenesis. Sufu and Kif7 play opposing roles in Hh signaling through the regulation of Gli2 subcellular distribution, and Kif7 performs distinct Sufu-dependent and –independent functions. In addition, deletion of both Sufu and Kif7 in embryonic skin leads to complete loss of follicular fate and compromised epidermal differentiation. In the adult skin, inactivation of Sufu does not drive BCC formation and requires additional genetic alterations such as the loss of Kif7. Using a Ptc1 mouse model for BCC, I have identified previously unrecognized molecular pathways and cellular events involved in BCC pathogenesis. This includes, aberrant cell cycle progression, loss of cell cycle checkpoint regulation, and suppression of the p53 response. Overall my work provides critical insight into the molecular control of Hh signaling and the downstream events driving BCC formation.

Page generated in 0.0603 seconds